Fig. 3
a-c: KA features of CCRCC a, AML b and RO c, respectively. A significant higher value was shown in AML (1.42 ± 0.23) than the rest renal tumors (0.86 ± 0.16 for RO, 0.57 ± 0.16 for CCRCC, P < 0.05)
Fig. 3 | Cancer Imaging
a-c: KA features of CCRCC a, AML b and RO c, respectively. A significant higher value was shown in AML (1.42 ± 0.23) than the rest renal tumors (0.86 ± 0.16 for RO, 0.57 ± 0.16 for CCRCC, P < 0.05)